La vendita allo scoperto per Envoy Medical dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Envoy Medical. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Envoy Medical (NASDAQ:COCH) Azioni, Report sulle vendite allo scoperto

Envoy Medical

Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.

Long Ideas

News

Penny Stocks

Insider Trades

Markets

Trading Ideas

Envoy Medical, Inc. - Class A Common Stock

COCH

HYLN

SXTP

Scopri le penny stock sotto i $5 in cui Hyliion e altri due titoli stanno attirando l&#39;attenzione degli insider.

Penny stock sotto i $5: Hyliion e altri 2 titoli sotto osservazione

Envoy Medical Inc

Cochlear Ltd

Needham analyst Mike Matson upgraded Inogen, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INGN#NASDAQ">INGN</a>) from Hold to Buy, <a target="_blank" href="https://www.benzinga.com/quote/INGN/analyst-ratings" rel="noreferrer noopener">with a price forecast of $12</a>.
On May 7, the company<a href="https://www.benzinga.com/pressreleases/25/05/b45265755/inogen-announces-first-quarter-2025-financial-results" target="_blank" rel="noreferrer noopener"> reported its first-quarter results.</a>
Total revenue in the quarter was $82.3 million, an increase of 5.5% from the prior-year period, or 7.1% at constant currency rates, due to higher demand from international and domestic business-to-business customers.
Matson highlighted the turnaround efforts led by the company&#8217;s new management team, which remains underappreciated by the market.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/upgrades/25/05/45562777/this-united-rentals-analyst-turns-bullish-here-are-top-5-upgrades-for-thursday" rel="noreferrer noopener">This United Rentals Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday</a>
The company has returned to mid-single-digit revenue growth, with expectations for further acceleration in the second half of 2025 and into 2026.
Matson also notes improvements in margin performance and highlights management&#8217;s strategy to expand Inogen&#8217;s focus beyond its core offerings into a more diversified respiratory device portfolio, which introduces multiple new avenues for growth.
He added that management anticipates nearing adjusted EBITDA breakeven in 2025, which he views as a positive indicator of progress.
Matson writes that the decline in Inogen&#8217;s direct-to-consumer sales has primarily stemmed from a smaller DTC sales force.
The analyst also projects margins to improve further as direct-to-consumer sales stabilize or return to growth, especially after the impact of the sales force reduction is fully reflected in the fourth quarter of 2025.
Price Action: INGN shares are trading higher by 14% to $6.795 at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45551302/5-undervalued-stocks-to-buy-on-china-tariff-cuts" target="_blank" rel="noreferrer noopener">5 Undervalued Stocks To Buy On China Tariff Cuts</a></li>
</ul>
Photo: Shutterstock

Equities

Analyst Ratings

General

INGN

Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough

Citigroup analyst Joanne Wuensch maintains Sight Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGHT#NASDAQ">SGHT</a>) with a Neutral and raises the price target from $3.2 to $3.6.

Price Target

SGHT

Citigroup Maintains Neutral on Sight Sciences, Raises Price Target to $3.6

Guess?, Inc. and its partner global brand management firm WHP Global, which jointly owns the New York-based fashion brand rag &amp; bone, announce a four-year exclusive licensee partnership with Marcolin - a longtime GUESS licensee partner and leading manufacturer of premium eyewear - to design, produce and distribute a new line of premium sunglasses and eyeglasses for rag &amp; bone.
The new eyewear collection will be available at rag &amp; bone boutiques, rag-bone.com and in select eyewear stores and authorized retailers.
 &nbsp;

Guess? And WHP Global Announce 4-Yr Exclusive Licensee Partnership With Marcolin To Design, Produce And Distribute New Line Of Premium Sunglasses And Eyeglasses For Rag & Bone

Citigroup analyst Joanne Wuensch maintains Pulmonx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNG#NASDAQ">LUNG</a>) with a Neutral and lowers the price target from $6.5 to $4.15.

LUNG

Citigroup Maintains Neutral on Pulmonx, Lowers Price Target to $4.15

Citigroup analyst Joanne Wuensch maintains iRhythm Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>) with a Buy and raises the price target from $130 to $167.

IRTC

Citigroup Maintains Buy on iRhythm Technologies, Raises Price Target to $167

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Health Care sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>UNH</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>05/23/25</td>
<td>$300.00</td>
<td>$25.7K</td>
<td>6.4K</td>
<td>7.0K</td>
</tr>
<tr>
<td>MDT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/27/25</td>
<td>$76.00</td>
<td>$244.0K</td>
<td>10</td>
<td>4.0K</td>
</tr>
<tr>
<td>LLY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$1000.00</td>
<td>$25.6K</td>
<td>361</td>
<td>274</td>
</tr>
<tr>
<td>SYK</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$400.00</td>
<td>$52.8K</td>
<td>46</td>
<td>15</td>
</tr>
<tr>
<td>VRTX</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/18/26</td>
<td>$450.00</td>
<td>$30.4K</td>
<td>93</td>
<td>6</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• For UNH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), we notice a put option trade that happens to be neutral, expiring in 1 day(s) on May 23, 2025. This event was a transfer of 60 contract(s) at a $300.00 strike. The total cost received by the writing party (or parties) was $25.7K, with a price of $429.0 per contract. There were 6422 open contracts at this strike prior to today, and today 7074 contract(s) were bought and sold. 
• For MDT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDT#NYSE">MDT</a>), we notice a put option trade that happens to be bullish, expiring in 36 day(s) on June 27, 2025. This event was a transfer of 4000 contract(s) at a $76.00 strike. The total cost received by the writing party (or parties) was $244.0K, with a price of $61.0 per contract. There were 10 open contracts at this strike prior to today, and today 4000 contract(s) were bought and sold. 
• Regarding LLY (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), we observe a call option sweep with bearish sentiment. It expires in 85 day(s) on August 15, 2025. Parties traded 54 contract(s) at a $1000.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $25.6K, with a price of $475.0 per contract. There were 361 open contracts at this strike prior to today, and today 274 contract(s) were bought and sold. 
• For SYK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYK#NYSE">SYK</a>), we notice a put option sweep that happens to be bullish, expiring in 392 day(s) on June 18, 2026. This event was a transfer of 12 contract(s) at a $400.00 strike. This particular put needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $52.8K, with a price of $4400.0 per contract. There were 46 open contracts at this strike prior to today, and today 15 contract(s) were bought and sold. 
• For VRTX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>), we notice a put option trade that happens to be neutral, expiring in 392 day(s) on June 18, 2026. This event was a transfer of 5 contract(s) at a $450.00 strike. The total cost received by the writing party (or parties) was $30.4K, with a price of $6080.0 per contract. There were 93 open contracts at this strike prior to today, and today 6 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

VRTX

5 Health Care Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/23/25</td>
<td>$350.00</td>
<td>$35.2K</td>
<td>24.6K</td>
<td>65.7K</td>
</tr>
<tr>
<td>PDD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/15/25</td>
<td>$140.00</td>
<td>$108.0K</td>
<td>1.7K</td>
<td>2.5K</td>
</tr>
<tr>
<td>AEO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/30/25</td>
<td>$10.00</td>
<td>$40.2K</td>
<td>611</td>
<td>2.0K</td>
</tr>
<tr>
<td>GME</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$40.00</td>
<td>$44.5K</td>
<td>6.7K</td>
<td>646</td>
</tr>
<tr>
<td>AMZN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$175.00</td>
<td>$133.6K</td>
<td>5.7K</td>
<td>224</td>
</tr>
<tr>
<td>BABA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$100.00</td>
<td>$38.6K</td>
<td>2.9K</td>
<td>48</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding TSLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), we observe a call option sweep with bullish sentiment. It expires in 1 day(s) on May 23, 2025. Parties traded 128 contract(s) at a $350.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $35.2K, with a price of $275.0 per contract. There were 24675 open contracts at this strike prior to today, and today 65724 contract(s) were bought and sold. 
• Regarding PDD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>), we observe a call option trade with neutral sentiment. It expires in 85 day(s) on August 15, 2025. Parties traded 300 contract(s) at a $140.00 strike. The total cost received by the writing party (or parties) was $108.0K, with a price of $360.0 per contract. There were 1725 open contracts at this strike prior to today, and today 2550 contract(s) were bought and sold. 
• For AEO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEO#NYSE">AEO</a>), we notice a put option sweep that happens to be bullish, expiring in 8 day(s) on May 30, 2025. This event was a transfer of 2000 contract(s) at a $10.00 strike. This particular put needed to be split into 57 different trades to become filled. The total cost received by the writing party (or parties) was $40.2K, with a price of $20.0 per contract. There were 611 open contracts at this strike prior to today, and today 2040 contract(s) were bought and sold. 
• For GME (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>), we notice a call option trade that happens to be bearish, expiring in 239 day(s) on January 16, 2026. This event was a transfer of 100 contract(s) at a $40.00 strike. The total cost received by the writing party (or parties) was $44.5K, with a price of $445.0 per contract. There were 6786 open contracts at this strike prior to today, and today 646 contract(s) were bought and sold. 
• Regarding AMZN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), we observe a put option sweep with bullish sentiment. It expires in 302 day(s) on March 20, 2026. Parties traded 127 contract(s) at a $175.00 strike. This particular put needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $133.6K, with a price of $1050.0 per contract. There were 5798 open contracts at this strike prior to today, and today 224 contract(s) were bought and sold. 
• For BABA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), we notice a put option trade that happens to be bearish, expiring in 603 day(s) on January 15, 2027. This event was a transfer of 35 contract(s) at a $100.00 strike. The total cost received by the writing party (or parties) was $38.6K, with a price of $1105.0 per contract. There were 2953 open contracts at this strike prior to today, and today 48 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMZN

BABA

Citigourp Global Markets 2% Protected Notes Linked To The Djia

TSLA

6 Consumer Discretionary Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Information Technology sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AAPL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/23/25</td>
<td>$200.00</td>
<td>$45.5K</td>
<td>16.2K</td>
<td>31.7K</td>
</tr>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/30/25</td>
<td>$140.00</td>
<td>$81.5K</td>
<td>67.4K</td>
<td>15.0K</td>
</tr>
<tr>
<td>MSTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/23/25</td>
<td>$435.00</td>
<td>$95.5K</td>
<td>16.5K</td>
<td>13.8K</td>
</tr>
<tr>
<td>NVTS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$5.00</td>
<td>$37.5K</td>
<td>615</td>
<td>13.0K</td>
</tr>
<tr>
<td>IONQ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$44.00</td>
<td>$94.6K</td>
<td>0</td>
<td>4.6K</td>
</tr>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$500.00</td>
<td>$66.0K</td>
<td>7.1K</td>
<td>4.4K</td>
</tr>
<tr>
<td>WOLF</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$1.00</td>
<td>$62.8K</td>
<td>1.7K</td>
<td>3.3K</td>
</tr>
<tr>
<td>TXN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$195.00</td>
<td>$395.0K</td>
<td>2.4K</td>
<td>1.7K</td>
</tr>
<tr>
<td>INTC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$21.50</td>
<td>$114.0K</td>
<td>5.4K</td>
<td>1.5K</td>
</tr>
<tr>
<td>SAP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$300.00</td>
<td>$45.7K</td>
<td>1.9K</td>
<td>857</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For AAPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), we notice a put option sweep that happens to be bearish, expiring in 1 day(s) on May 23, 2025. This event was a transfer of 500 contract(s) at a $200.00 strike. This particular put needed to be split into 47 different trades to become filled. The total cost received by the writing party (or parties) was $45.5K, with a price of $91.0 per contract. There were 16210 open contracts at this strike prior to today, and today 31741 contract(s) were bought and sold. 
• For NVDA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), we notice a call option sweep that happens to be bullish, expiring in 8 day(s) on May 30, 2025. This event was a transfer of 284 contract(s) at a $140.00 strike. This particular call needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $81.5K, with a price of $287.0 per contract. There were 67491 open contracts at this strike prior to today, and today 15032 contract(s) were bought and sold. 
• For MSTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), we notice a call option sweep that happens to be bearish, expiring in 1 day(s) on May 23, 2025. This event was a transfer of 985 contract(s) at a $435.00 strike. This particular call needed to be split into 21 different trades to become filled. The total cost received by the writing party (or parties) was $95.5K, with a price of $97.0 per contract. There were 16561 open contracts at this strike prior to today, and today 13812 contract(s) were bought and sold. 
• Regarding NVTS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>), we observe a call option sweep with bearish sentiment. It expires in 29 day(s) on June 20, 2025. Parties traded 500 contract(s) at a $5.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $37.5K, with a price of $75.0 per contract. There were 615 open contracts at this strike prior to today, and today 13000 contract(s) were bought and sold. 
• Regarding IONQ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>), we observe a put option sweep with bearish sentiment. It expires in 29 day(s) on June 20, 2025. Parties traded 161 contract(s) at a $44.00 strike. This particular put needed to be split into 8 different trades to become filled. The total cost received by the writing party (or parties) was $94.6K, with a price of $580.0 per contract. There were 0 open contracts at this strike prior to today, and today 4604 contract(s) were bought and sold. 
• For MSFT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), we notice a call option sweep that happens to be bullish, expiring in 85 day(s) on August 15, 2025. This event was a transfer of 112 contract(s) at a $500.00 strike. This particular call needed to be split into 24 different trades to become filled. The total cost received by the writing party (or parties) was $66.0K, with a price of $590.0 per contract. There were 7114 open contracts at this strike prior to today, and today 4434 contract(s) were bought and sold. 
• Regarding WOLF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>), we observe a put option trade with bearish sentiment. It expires in 302 day(s) on March 20, 2026. Parties traded 806 contract(s) at a $1.00 strike. The total cost received by the writing party (or parties) was $62.8K, with a price of $78.0 per contract. There were 1701 open contracts at this strike prior to today, and today 3386 contract(s) were bought and sold. 
• Regarding TXN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>), we observe a call option trade with bullish sentiment. It expires in 57 day(s) on July 18, 2025. Parties traded 1000 contract(s) at a $195.00 strike. The total cost received by the writing party (or parties) was $395.0K, with a price of $395.0 per contract. There were 2484 open contracts at this strike prior to today, and today 1720 contract(s) were bought and sold. 
• Regarding INTC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>), we observe a call option trade with bullish sentiment. It expires in 29 day(s) on June 20, 2025. Parties traded 1500 contract(s) at a $21.50 strike. The total cost received by the writing party (or parties) was $114.0K, with a price of $76.0 per contract. There were 5468 open contracts at this strike prior to today, and today 1582 contract(s) were bought and sold. 
• For SAP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAP#NYSE">SAP</a>), we notice a call option sweep that happens to be bullish, expiring in 29 day(s) on June 20, 2025. This event was a transfer of 52 contract(s) at a $300.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $45.7K, with a price of $880.0 per contract. There were 1919 open contracts at this strike prior to today, and today 857 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAPL

INTC

IONQ

MSFT

MSTR

NVDA

NVTS

WOLF

10 Information Technology Stocks Whale Activity In Today's Session

WIIM

ALAB

Astera Labs shares are trading higher after William Blair initiated coverage on the stock with an Outperform rating.

<h2 class="wp-block-heading">Zinger Points:</h2>
<ul class="wp-block-list">
<li>Chime reports a $13 million Q1 profit after narrowing 2024 net loss to $25 million — a </li>
<li>Some 76% of Chime's revenue still comes from interchange fees despite efforts to diversify.</li>
<li>With $518 million in 2024 marketing spend, Chime doubles down on Gen Z growth ahead of IPO.</li>
</ul>
Digital banking disruptor Chime has filed for an IPO, positioning itself as the first major fintech to test public markets after a period of market uncertainty, particularly influenced by President Donald Trump&#8216;s recent tariff policies.&nbsp;
The San Francisco-based neobank reported $518.7 million in revenue and $12.9 million in net income for the first quarter of 2025, a 32% year-over-year increase, according to its <a href="https://www.sec.gov/Archives/edgar/data/1795586/000162828025025059/chimefinancialinc-sx1wq1da.htm">registration statement filed</a> last week with the U.S. Securities and Exchange Commission. While profit dipped slightly from the previous quarter, the company's operational momentum and 8.6 million active members underscore its readiness to go public.&nbsp;
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
The IPO, underwritten by Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>), Goldman Sachs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), and JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), could value the company between $20 billion and $25 billion, based on projections in the filing.
The timing is strategic. Chime's IPO comes just weeks after trading platform eToro's successful public debut. Founded in 2012, Chime has raised $2.65 billion from blue-chip investors including SoftBank, General Atlantic, and Tiger Global — a war chest that helped it capture 18 million account holders. Chime's appeal to digital-native, mobile-first users makes its move particularly bold, as it targets a segment that has historically been underserved by traditional banks yet increasingly drives financial innovation.
<h2 class="wp-block-heading">Youth Movement Meets Market Volatility</h2>
According to registration statement, Chime posted $2.1 billion in revenue in 2024 — a 38% increase from the prior year — while narrowing its net loss from $203 million to $25 million. Other metrics also point to strong engagement: 78% of users log in daily, and 43% use its early paycheck access feature.
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a>
But risks loom. While the company hasn&#8217;t disclosed share count or pricing, analysts note Chime's continued dependence on interchange fees — 76% of total revenue in 2024, down from 80% two years earlier — could expose it to regulatory shifts, Forbes reported. Its young user base also maintains lower average balances than traditional bank customers, according to the SEC filing. The company, which plans to list on the Nasdaq under ticker symbol CHYM, is aiming to go public later this year.
<h2 class="wp-block-heading">The Tariff Wildcard</h2>
The IPO landscape showed tentative signs of revival in March, when AI infrastructure firm CoreWeave Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>)'s <a href="https://in.benzinga.com/content/45335117/investing-in-coreweave-key-insights-on-the-nvidia-backed-ai-ipo">successful debut</a> broke a prolonged tech listing drought. That momentum stalled abruptly in April, as <a href="https://in.benzinga.com/25/04/44878334/trumps-tariffs-just-slammed-the-ipo-window-shut-for-fintech">Trump's renewed tariff threats</a> on Chinese imports rattled markets. Klarna, StubHub, and initially even Chime, postponed their offerings, according to media reports. Now, Chime's decision to proceed positions it as a test case for whether fintechs can navigate the current geopolitical climate to access public markets. The move comes just weeks after eToro's well-received listing, <a href="https://www.bloomberg.com/news/articles/2025-05-14/trading-platform-etoro-surges-42-after-620-million-upsized-ipo">Bloomberg</a> reported, suggesting cautious optimism may be returning to the sector.
Market observers will be watching how the IPO&#8217;s structure takes shape in the coming weeks, especially given the involvement of bulge-bracket underwriters. As the first fintech to test Wall Street's appetite in this new era of trade tensions, Chime's performance could set the tone for a wave of public offerings — or reinforce investor caution.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
</ul>
Image: Shutterstock

CRWV

Chime Files For IPO, Betting On Gen Z To Power Fintech's Market Comeback

Seagate shares are trading higher after the company approved a $5 billion share buyback,

Ralph Lauren shares are trading higher after the company reported better-than-expected Q4 financial results.

Citigroup analyst Joanne Wuensch maintains DexCom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) with a Buy and raises the price target from $82 to $102.

DXCM

Citigroup Maintains Buy on DexCom, Raises Price Target to $102

Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) with a Buy and raises the price target from $119 to $125.

Citigroup Maintains Buy on Boston Scientific, Raises Price Target to $125

Chinese carmaker BYD Company ADR (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDY#OTC">BYDDY</a>) might have stolen the April electric vehicle title in Europe, but markets didn&#8217;t bat an eyelid. Neither did Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares.
<a href="https://www.benzinga.com/25/05/45564693/byd-outsells-elon-musks-tesla-amid-european-plans-shift-into-gear">BYD sold 7,231 battery electric cars (BEVs) in Europe in April</a>, edging out Tesla, which sold 7,165, new figures from JATO Dynamics show. Although the milestone represents a symbolic turning point in the European EV battle, it didn&#8217;t dent investor faith, as Tesla shares gained more than 2% on the day of the news.
It's the first time a Chinese brand has outsold Tesla in Europe's BEV segment, a region where the U.S. automaker has long held the pole position. BYD's ascent has been swift: the company began serious expansion into Europe only in late 2022. 
But markets appear to be betting that it&#8217;s only short-term turbulence for Tesla.
<h1 class="wp-block-heading">ETF Exposure: Why Tesla Still Matters</h1>
Tesla&#8217;s short fall in European rankings will be a speed bump, but for <a href="https://www.benzinga.com/etfs">ETFs tracking the EV and clean energy theme</a>, the larger picture still seems intact. 
Tesla is still a top holding in many of the large ETFs, like the ARK Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#BATS">ARKK</a>), Global X Autonomous &amp; Electric Vehicles ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRIV#NASDAQ">DRIV</a>), and iShares Self-Driving EV and Tech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDRV#NYSE">IDRV</a>), and today&#8217;s market response indicates that few are heading for the exits.
ARKK continues to hold a significant stake in Tesla (12.95%), relying on its push into autonomous mobility, artificial intelligence, and robotics. The upcoming robotaxi pilot and production of the Cybercab next year are part of ARKK's high-conviction, future-focused strategy. For investors betting on transformative tech, Tesla is still a solid play. The fund was up 1.42% at publication on Thursday.
ETFs like DRIV and IDRV has a wider exposure across the EV supply chain, including traditional automakers, chipmakers and software providers. Tesla is still one of the top holdings in both, but these funds also include companies like NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Toyota Motor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TM#NYSE">TM</a>), and Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), which help cushion any Tesla-specific volatility. 
This diversified approach makes it attractive to investors looking to benefit from the EV trend without putting all their chips on one automaker. Interestingly, though, IDRIV has rejigged its portfolio to dedicate the largest percentage distribution to BYD. Both the funds were fairly non-reactive to the news today.
Also Read: <a href="https://www.benzinga.com/markets/equities/25/05/45557873/tesla-bull-dan-ives-thinks-elon-musks-ev-giant-could-be-entering-a-golden-era-says-2-trillion-market-cap-on-the-table">Tesla Bull Dan Ives Thinks Elon Musk&#8217;s EV Giant Could Be Entering A &#8216;Golden Era,&#8217; Says 2 Trillion Market Cap &#8216;On The Table&#8217;</a>
<h1 class="wp-block-heading">Short-Term Wobble, Long-Term Vision</h1>
Tesla&#8217;s recent delivery downturn, continuing production interruptions and waiting for updated models such as the new Model Y have caused short-term headwinds. 
The stock is down more than 9% so far this year on an aggregate. Nevertheless, the company&#8217;s long-term strategy, backed by robotaxis, AI-based innovations, energy storage and next-generation vehicle platforms, is still compelling. Tesla&#8217;s pilot robotaxi launch will start as early as June in Austin, while a larger commercial fleet (Cybercab) is scheduled for 2026. 
For ETFs such as ARKK, which are constructed on narratives of innovation, Tesla still fits the thesis.
<h1 class="wp-block-heading">BYD&#8217;s Rise = A Diversification Opportunity</h1>
BYD&#8217;s increasing foothold in Europe, despite the tariffs on Chinese manufacturers imposed by the European Union, underscores the need for geographic diversification across EV ETFs. Funds like KraneShares Electric Vehicles and Future Mobility ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KARS#NYSE">KARS</a>), which encompass both Western and Chinese carmakers, are uniquely positioned to capitalize on the worldwide nature of EV growth. BYD is also growing rapidly, doubling international sales in April on a year-over-year basis, and establishing manufacturing platforms in Hungary and Turkey to circumvent EU import tariffs.
<h1 class="wp-block-heading">ESG Considerations And Musk&#8217;s Shadow</h1>
Tesla CEO Elon Musk, remains a magnet for attention, some of it unwanted. Protests and controversy surrounding his politics have generated backlash in the U.S. and Europe, creating an overhang for ESG-oriented funds. Nevertheless, for most ETFs, the firm&#8217;s role in electrification and renewable energy exceeds the reputation risk, at least in the short term.
<h1 class="wp-block-heading">Room To Grow</h1>
Tesla&#8217;s affordability, volume expansion, and capital-free manufacturing focus is unbroken. The firm is targeting lower-cost models and expanding production with minimal incremental capital, aiming for a 60% uplift ratio over 2024 levels. Its energy segment is also picking up, with record Powerwall installations and expanding margins.
<h1 class="wp-block-heading">Conclusion</h1>
BYD&#8217;s passing of Tesla in Europe&#8217;s EV rankings is news-worthy, but not necessarily the turning point. ETF investors and the broader market seem to be seeing through the noise and concentrating on fundamentals. Tesla might be facing choppy waters today, but it remains an ETF pick and is at the center of the future of mobility and innovation.
As the EV industry continues to grow, ETFs that accept Tesla&#8217;s long-term vision along with the emergence of legitimate challengers such as BYD might be the most balanced way to go.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45570155/new-usng-etf-targets-natural-gas-infrastructure-amid-rising-energy-demand">Amplify, Samsung Launch Natural Gas ETF To Power Up AI-Era Infrastructure Boom</a></li>
</ul>

Sector ETFs

Global

ETFs

ARKK

BYDDY

DRIV

IDRV

KARS

BYD Outsells Tesla In Europe, But These ETFs Still Back Elon's EV Empire

Shares of Urban Outfitters Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) rallied after the company Wednesday reported its <a href="https://www.benzinga.com/news/earnings/25/05/45553566/urban-outfitters-shares-rally-on-record-q1-revenues-details">first-quarter results</a>.
The announcement came amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
JPMorgan On Urban Outfitters
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/586bcbd9351b9b0001ab738c/matthew-boss">Analyst Matthew Boss</a> reiterated an Overweight rating while raising the price target from $63 to $78.
Urban Outfitters reported quarterly earnings of $1.16 per share, 38% above Street expectations of 84 cents per share, Boss said in a note. He added that the outperformance was driven by same-store-sales growth of 5%, coming in above expectations of 3.4%, and adjusted gross margin expansion of 240 (basis points) bps year-on-year to 36.8%.
The quarter's same-store-sales growth "included positive comp growth across all three banners," which has happened for the first time in three years, the analyst wrote. For the second quarter, management guided to high-single-digit percentage growth in consolidated sales growth, with mid-single-digit percentage growth in same-store sales, above Street's 3.4% projection, he further stated.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Telsey Advisory Group On Urban Outfitters
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5888c53977f9dd0001877a22/dana-telsey">Analyst Dana Telsey</a> maintained a Market Perform rating, while lifting the price target from $59 to $72.
Telsey said that Urban Outfitters' adjusted earnings grew to $1.16 per share from 69 cents per share in the same quarter last year. Total sales grew 10.7% to $1.330 billion, surpassing consensus of 7.6% to $1.292 billion, she added.  
"After a solid finish to FY24, momentum continued into FY25 with a healthy beat across the board in the first quarter," the analyst wrote. The second-quarter guidance was "encouraging," given the challenging macro environment, as it reflects "continued topline momentum across brands along with margin expansion and earnings growth," she further stated. &nbsp;
URBN Price Action: Shares of Urban Outfitters had risen by 22.01% to $72.72 at the time of publication on Thursday.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45262278/under-armour-faces-tough-road-ahead-says-analyst"> Urban Outfitters Navigates Tariff Headwinds With Diversification Strategies: No Country &#8216;Accounts For More Than 25%&#8217; Of Production</a></li>
</ul>
Photo: Vladislav Gajic/Shutterstock

Analyst Color

Earnings Beats

Reiteration

Movers

URBN

Urban Outfitters Surges After Q1 Beat: Analysts Highlight Margin Strength, Sales Momentum

Newmark Group, Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/NMRK#NASDAQ">NMRK</a>) ("Newmark" or "the Company"), a leading commercial real estate advisor and service provider to large institutional investors, global corporations, and other owners and occupiers, announces the company arranged a $7.1 billion construction loan for Blue Owl Capital, Inc., Crusoe and Primary Digital Infrastructure. The loan, provided by a consortium led by J.P. Morgan, will fund the second phase of a <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4434036-1&amp;h=2693766533&amp;u=https%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2025%2F05%2F21%2F3085765%2F0%2Fen%2FCrusoe-Blue-Owl-Capital-and-Primary-Digital-Infrastructure-Enter-Second-Phase-of-15-Billion-Joint-Venture-to-Fund-AI-Data-Center-in-Abilene-Texas.html&amp;a=%2415+billion+joint+venture">$15 billion joint venture</a> to fund a 1.2-gigawatt AI data center in Abilene, Texas.
Under the terms of the joint venture, Crusoe in combination with funds managed by Blue Owl's Real Assets platform along with Primary Digital Infrastructure will jointly sponsor the construction of six new buildings, which will bring the center to eight buildings upon completion. Construction of the first phase, comprising two buildings and 200+ megawatts, began in June 2024 and is expected to be energized in the first half of 2025. Construction of the second phase, consisting of the six additional buildings and a total of 1.2 gigawatts, began in March 2025 and is expected to be energized in mid-2026, setting a new bar for the speed of delivery for greenfield, hyperscale digital infrastructure projects.

NMRK

Newmark Group Arranges $7.1B Construction Loan For Blue Owl Capital, Crusoe And Primary Digital Infrastructure

<a href="https://cloud.google.com/blog/products/ai-machine-learning/anthropics-claude-opus-4-and-claude-sonnet-4-on-vertex-ai/" title="https://cloud.google.com/blog/products/ai-machine-learning/anthropics-claude-opus-4-and-claude-sonnet-4-on-vertex-ai/">https://cloud.google.com/blog/products/ai-machine-learning/anthropics-claude-opus-4-and-claude-sonnet-4-on-vertex-ai/</a>

GOOG

GOOGL

Update: 'Announcing Anthropic's Claude Opus 4 and Claude Sonnet 4 on Vertex AI' - Google Cloud

Citigroup analyst Alicia Yap maintains Baidu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) with a Buy and lowers the price target from $139 to $138.

BIDU

Citigroup Maintains Buy on Baidu, Lowers Price Target to $138

Utilities ETFs are trading lower. Weakness may be due to recent strength in Treasury yields, which could drive a rotation out of income-paying sectors.

Press Releases

Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study

Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio

First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant

Envoy Medical to Participate in the 37th Annual ROTH Conference

Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device

Hearing Device Coverage Clarification Act Reintroduced in House and Senate

Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results

EdgarAgents Debuts EA34 Plugin at Centri Capital Conference to Simplify and Expedite Financial Filing Process for Mid-to-Microcap Companies

Envoy Medical Reports on First Quarter 2025 Results

Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial

Adagio Medical Holdings, Inc - Common Stock

Adagio Medical Holdings

Apyx Medical

HeartBeam

CytoSorbents

DIH Holding US, Inc. - Class A Common Stock

DIH Holding US

Daxor

electroCore

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

Comments

Envoy Medical

Vendite allo scoperto

Envoy Medical (NASDAQ:COCH) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO